Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signalling

Pham, SH; Vuorinen, SI; Arif, KMT; Griffiths, LR; Okolicsanyi, RK; Haupt, LM

Haupt, LM (通讯作者)，Queensland Univ Technol, Ctr Genom & Personalised Hlth, Genom Res Ctr, Stem Cell & Neurogenesis Grp, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.

BIOCHIMIE, 2023; 207 (): 49

Abstract

Despite the use of the highly specific anti-HER2 receptor (trastuzumab) therapy, HER2-positive breast cancers account for 20-30% of all breast cancer ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索